Remedica Limited is appealing to patients using Remethan 100mg (anti-inflammatory) extended-release tablets, in the context of the voluntary recall of specific batches of the drug.
The company calls on those who take this preparation to immediately stop using it, if they have one of the batches affected by the recall, and to contact their attending physician or pharmacist, in order to receive instructions for its replacement with another available pharmaceutical preparation.
The announcement follows the update issued on July 1, 2026, with Remedica reminding that the product should also be returned to the pharmacy from which it was purchased.
Which lots does the recall concern?
The recall concerns the following batches of Remethan 100mg extended-release tablets:
98462 (expires 09/2026)
102141 (03/2027)
103797 (03/2027)
105515 (09/2027)
106374 (09/2027)
107171 (09/2027)
107818 (01/2028)
108262 (01/2028)
111115 (04/2028)
113029 (09/2028)
115344 (01/2029)
116856 (03/2029)
118658 (06/2029)
122934 (06/2029)
127806 (11/2030)
According to Remedica, batches with numbers 116856, 122934, and 127806 may still be available on the market, which makes it important for patients to carefully check the batch number on their medication packaging.
What conditions is Remethan used for?
Remethan 100mg is a widely used non-steroidal anti-inflammatory drug (NSAID) with diclofenac as the active ingredient, which is administered to relieve pain and inflammation.
It is mainly used to treat conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, but also to treat musculoskeletal injuries, such as sprains and tendonitis, as well as pain after certain surgical or dental procedures.
What patients should do
The company emphasizes that patients who have one of these batches should not continue using the drug, but should contact their doctor or pharmacist to ensure appropriate alternative treatment.
At the same time, they are asked to return the product to the pharmacy, so that the voluntary recall process can be completed.
